FDA Adverse Event Death Summary report: N

SYMBOTEX

MDR report key: 19490305 · Received June 7, 2024

Report

Report Number
9615742-2024-00811
Event Type
Death
Date Received
June 7, 2024
Date of Event
May 10, 2024
Report Date
June 27, 2024
Manufacturer
SOFRADIM PRODUCTION SAS
Product Code
FTL
UDI-DI
10884521190511
PMA / PMN Number
K142908
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Additional Manufacturer Narrative · 0

MEDTRONIC SUBMITS THIS REPORT TO COMPLY WITH FDA REGULATIONS 21 CFR PARTS 4 AND 803. MEDTRONIC HAS MADE REASONABLE EFFORTS TO PROVIDE AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. MEDTRONIC WILL SUBMIT A SUPPLEMENTAL REPORT IF ADDITIONAL RELEVANT INFORMATION BECOMES KNOWN.

Description of Event or Problem · 0

ACCORDING TO THE REPORTER, DURING AN OPEN VENTRAL HERNIA PROCEDURE ON A PATIENT DUE TO HERNIA INCARCERATION, MECHANICAL ILEUS, AND VISCERAL ATTACHMENTS AS RESULT OF PREVIOUS MEDICAL CONDITION, A MESH WAS USED IN IDEAL CONDITION USING THE INLAY TECHNIQUE AND WAS FIXATED BY SUTURES. HOWEVER, THREE MONTHS LATER, THE PATIENT CAME TO THE HOSPITAL WITH HYPERTENSION, HEART FIBRILLATION, AND WITH CLINICAL PICTURE OF ACUTE ABDOMEN. THE PATIENT HAD TISSUE DAMAGE DUE TO INTESTINAL PERFORATION. THE SURGEON PERFORMED EXTIRPATION OF PARTS OF THE MESH, RESECTION OF SMALL INTESTINES, ILEOSTOMY WITH TERMINAL ILEOFISTULA, AND DRAINAGE. THE PATIENT DIED A DAY AFTER THE PROCEDURE.

Description of Event or Problem · 0

ACCORDING TO THE REPORTER, DURING AN OPEN VENTRAL HERNIA PROCEDURE ON A PATIENT DUE TO HERNIA INCARCERATION, MECHANICAL ILEUS, AND VISCERAL ATTACHMENTS AS RESULT OF PREVIOUS MEDICAL CONDITION, A MESH WAS USED IN IDEAL CONDITION USING THE INLAY TECHNIQUE AND WAS FIXATED BY SUTURES. HOWEVER, THREE MONTHS LATER, THE PATIENT CAME TO THE HOSPITAL WITH HYPERTENSION, HEART FIBRILLATION, AND WITH CLINICAL PICTURE OF ACUTE ABDOMEN. THE PATIENT HAD TISSUE DAMAGE DUE TO INTESTINAL PERFORATION. THE SURGEON PERFORMED EXTIRPATION OF PARTS OF THE MESH, RESECTION OF SMALL INTESTINES, ILEOSTOMY WITH TERMINAL ILEOFISTULA, AND DRAINAGE. THE REACTION BETWEEN THE MESH AND THE BOWEL THAT THE MESH HAD BEEN ADHERENT TO, HAVE CAUSED THE NECROSIS OF THE BOWEL AND THE PERFORATION OF THE BOWEL. DURING THE SURGERY, THE MESH WAS EXCISED, AND IT WAS NOT PRESERVED. THE PATIENT WAS ADMITTED TO THE INTENSIVE CARE UNIT POST-OPERATIVE. IN THE INTENSIVE CARE UNIT, THE PATIENT WAS ON MECHANICAL VENTILATION AND INOTROPIC SUPPORT WITH OTHER MEDICATIONS AND INFUSIONAL REHYDRATION METHODS. THE PATIENT DIED THE FOLLOWING DAY DUE TO ENDOGENOUS INTOXICATION CAUSED BY PERFORATION OF THE BOWEL AND PERITONITIS AND SUBSEQUENT SEPSIS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1310267 SYMBOTEX MESH, SURGICAL, POLYMERIC FTL SOFRADIM PRODUCTION SAS SYM3020 PWI1459X 10884521190511

Patients

Seq Age Sex Outcome Treatment
1 NA Female Hospitalization| D| R